Completed
Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis
NCT05186805
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
- Locations
-
- Dermavant Investigative Site Thousand Oaks, California, United States
- Dermavant Investigative Site Centennial, Colorado, United States
- Dermavant Investigative Site Coral Gables, Florida, United States
- Dermavant Investigative Site Hialeah, Florida, United States